BridgeBio Oncology Therapeutics (BBOT) Financials: Revenue & Earnings
BBOT$2.69-0.01 -0.19%
$215.27M
Market Cap
—
P/E
—
Forward P/E
—
Score
BridgeBio Oncology Therapeutics (BBOT) Financials: Revenue & Earnings
BBOT price $2.69 -0.01 -0.19%
- Ticker
- BBOT
- Price
- $2.69
- Change
- -0.01 -0.19%
- Market cap ?
- $215.27M
- Beta ?
- 0.39
- Sector
- Healthcare
- Industry
- Biotechnology
Fair value
BBOT fair value Not meaningful. Price $2.69.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Not meaningful
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-11 | — | -0.69 | — | — |
| 2026-08-11 | -0.71 | -0.56 | — | — |
| 2026-05-12 | -0.48 | -0.51 | — | — |
| 2026-03-05 | -0.49 | -0.63 | — | — |
| 2025-11-12 | -1.03 | -0.38 | — | — |
| 2025-08-01 | -50.34 | -42.45 | — | — |
| 2025-05-15 | -52.15 | — | — | — |
| 2025-03-11 | 0.12 | — | — | — |
| 2024-11-14 | -0.74 | — | — | — |
| 2024-08-14 | 0.09 | — | — | — |
| 2024-05-15 | 0.05 | — | — | — |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-10-21 | Cobo Marc | Sell | 203 | $2.68 | 544 |
| 2026-10-01 | Cobo Marc | Sell | 126 | $3.94 | 496 |
| 2026-10-01 | Elmelech Idan | Sell | 343 | $3.94 | 1.35K |
| 2026-10-01 | Beltran Pedro | Sell | 1.05K | $3.94 | 4.13K |
| 2026-10-01 | Ben Yong | Sell | 1.05K | $3.94 | 4.13K |
| 2026-09-10 | Cobo Marc | Buy | 43.70K | $5.52 | 241.22K |
| 2026-09-10 | Cobo Marc | Buy | 9.04K | — | — |
| 2026-09-10 | Cobo Marc | Sell | 203 | $5.52 | 1.12K |
| 2026-07-01 | Cobo Marc | Sell | 125 | $7.80 | 975 |
| 2026-07-01 | Elmelech Idan | Sell | 343 | $7.80 | 2.68K |
| 2026-07-01 | Ben Yong | Sell | 1.05K | $7.80 | 8.17K |
| 2026-07-01 | Beltran Pedro | Sell | 1.05K | $7.80 | 8.17K |
| 2026-07-01 | Chen Bihua | Buy | 130.87K | — | — |
| 2026-07-01 | Chen Bihua | Buy | 1.70M | — | — |
| 2026-07-01 | Chen Bihua | Buy | 2.69M | — | — |
| 2026-07-01 | Chen Bihua | Sell | 4.53M | — | — |
| 2026-06-16 | Tipirneni Praveen P. | Buy | 31.68K | $7.73 | 244.85K |
| 2026-06-16 | MCCORMICK FRANK | Buy | 31.68K | $7.73 | 244.85K |
| 2026-06-16 | Lebowitz Peter F | Buy | 7.29K | $7.73 | 56.34K |
| 2026-06-16 | Kelleher Raymond J. | Buy | 31.68K | $7.73 | 244.85K |
| 2026-06-16 | Chen Bihua | Buy | 31.68K | $7.73 | 244.85K |
| 2026-06-16 | Bauer Jake | Buy | 31.68K | $7.73 | 244.85K |
| 2026-06-16 | Kumar Neil | Buy | 31.68K | $7.73 | 244.85K |
| 2026-05-10 | Elmelech Idan | Buy | 758.22K | $7.66 | 5.81M |
| 2026-05-10 | Beltran Pedro | Buy | 1.10M | $7.66 | 8.46M |
| 2026-04-21 | Cobo Marc | Other | 0 | — | — |
| 2026-04-21 | Cobo Marc | Other | 129.09K | $9.59 | 1.24M |
| 2026-04-21 | Cobo Marc | Other | 25.12K | $10.19 | 256.02K |
| 2026-04-20 | Elmelech Idan | Other | 0 | — | — |
| 2026-04-20 | Elmelech Idan | Other | 129.68K | $4.17 | 540.76K |
| 2026-04-20 | Elmelech Idan | Other | 7.77K | $7.88 | 61.20K |
| 2026-04-20 | Elmelech Idan | Other | 104.54K | $9.59 | 1.00M |
| 2026-04-20 | Elmelech Idan | Other | 68.31K | $10.19 | 696.08K |
| 2026-04-01 | Ben Yong | Sell | 1.05K | $9.03 | 9.45K |
| 2026-04-01 | Beltran Pedro | Sell | 1.05K | $9.03 | 9.45K |
| 2026-04-01 | Mehra Uneek | Sell | 524 | $9.03 | 4.73K |
| 2026-03-24 | Lebowitz Peter F | Buy | 63.35K | $8.72 | 552.41K |
| 2026-03-24 | Lebowitz Peter F | Other | 0 | — | — |
| 2026-03-10 | Mehra Uneek | Buy | 105.00K | $10.19 | 1.07M |
| 2026-03-10 | Mehra Uneek | Buy | 23.33K | — | — |
| 2026-03-10 | Beltran Pedro | Buy | 210.00K | $10.19 | 2.14M |
| 2026-03-10 | Beltran Pedro | Buy | 46.67K | — | — |
| 2026-03-10 | Ben Yong | Buy | 210.00K | $10.19 | 2.14M |
| 2026-03-10 | Ben Yong | Buy | 46.67K | — | — |
| 2026-01-01 | Wallace Eli M. | Buy | 1.11M | $12.52 | 13.95M |
| 2025-12-10 | Wallace Eli M. | Sell | 1.11M | $12.44 | 13.86M |
| 2025-10-10 | BridgeBio Pharma LLC | Buy | 784.72K | — | — |
| 2025-10-02 | Wallace Eli M. | Buy | 1.61M | $12.44 | 20.08M |
| 2025-08-26 | Tipirneni Praveen P. | Buy | 52.27K | $9.59 | 501.26K |
| 2025-08-26 | MCCORMICK FRANK | Buy | 91.08K | $9.59 | 873.42K |
| 2025-08-26 | Bauer Jake | Buy | 138.19K | $9.59 | 1.33M |
| 2025-08-26 | Beltran Pedro | Buy | 357.18K | $9.59 | 3.43M |
| 2025-08-26 | Ben Yong | Buy | 357.18K | $9.59 | 3.43M |
| 2025-08-26 | Wallace Eli M. | Buy | 499.73K | $9.59 | 4.79M |
| 2025-08-26 | Mehra Uneek | Buy | 633.57K | $9.59 | 6.08M |
| 2025-08-11 | Tipirneni Praveen P. | Other | 81.07K | $5.18 | 419.94K |
| 2025-08-11 | Tipirneni Praveen P. | Other | 4.86K | $7.88 | 38.26K |
| 2025-08-11 | DOIG MICHELLE | Other | 0 | — | — |
| 2025-08-11 | MCCORMICK FRANK | Other | 141.87K | $4.17 | 591.60K |
| 2025-08-11 | MCCORMICK FRANK | Other | 8.50K | $7.88 | 66.96K |
| 2025-08-11 | BridgeBio Pharma LLC | Other | 0 | — | — |
| 2025-08-11 | BridgeBio Pharma LLC | Other | 63.93K | $3.83 | 244.87K |
| 2025-08-11 | BridgeBio Pharma LLC | Other | 9.49K | $1.02 | 9.68K |
| 2025-08-11 | Bauer Jake | Other | 0 | — | — |
| 2025-08-11 | Kumar Neil | Other | 0 | — | — |
| 2025-08-11 | Ben Yong | Other | 443.30K | $4.17 | 1.85M |
| 2025-08-11 | Ben Yong | Other | 26.55K | $7.88 | 209.22K |
| 2025-08-11 | Wallace Eli M. | Other | 620.62K | $4.17 | 2.59M |
| 2025-08-11 | Wallace Eli M. | Other | 37.17K | $7.88 | 292.92K |
| 2025-08-11 | Mehra Uneek | Other | 0 | — | — |
| 2025-08-11 | Beltran Pedro | Other | 26.55K | $7.88 | 209.22K |
| 2025-08-11 | Beltran Pedro | Other | 443.30K | $4.17 | 1.85M |
| 2025-08-11 | Chen Bihua | Buy | 284.57K | — | — |
| 2025-08-11 | Chen Bihua | Buy | 5.60M | $10.72 | 60.00M |
| 2025-08-11 | Chen Bihua | Buy | 4.17M | $0.00 | 417 |
| 2025-08-11 | Chen Bihua | Sell | 152.94K | — | — |
| 2025-08-11 | Chen Bihua | Sell | 307.87K | — | — |
| 2025-08-11 | Chen Bihua | Buy | 1.76M | — | — |
| 2025-08-11 | Chen Bihua | Buy | 760.50K | $10.72 | 8.15M |
| 2025-08-11 | Chen Bihua | Buy | 1.91M | — | — |
| 2025-08-11 | Chen Bihua | Buy | 639.11K | $10.72 | 6.85M |
| 2025-08-11 | Chen Bihua | Sell | 4.17M | — | — |
| 2025-08-11 | Kelleher Raymond J. | Other | 0 | — | — |
| 2025-08-11 | Obradovic Nebojsa | Other | 0 | — | — |
| 2025-08-11 | Tripp Caleb | Other | 0 | — | — |
| 2025-08-11 | Holman Albert A III | Buy | 30.00K | — | — |
| 2025-08-11 | Holman Albert A III | Sell | 30.00K | — | — |
| 2025-08-11 | McKenna Mark C. | Buy | 30.00K | — | — |
| 2025-08-11 | McKenna Mark C. | Sell | 30.00K | — | — |
| 2025-08-11 | Schmid John P. | Buy | 30.00K | — | — |
| 2025-08-11 | Schmid John P. | Sell | 30.00K | — | — |
| 2025-02-08 | Holman Albert A III | Other | 30.00K | — | — |
| 2025-02-08 | Helix Holdings II LLC | Sell | 30.00K | — | — |
| 2025-02-08 | Chen Bihua | Sell | 30.00K | — | — |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 67, holders 0 vs prior quarter. Ownership 74219.11%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| CORMORANT ASSET MANAGEMENT, LP | 17.88M | 0 | 0.00% | 136.23M |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 4.89M | 0 | 0.00% | 37.23M |
| OMEGA FUND MANAGEMENT, LLC | 3.29M | 0 | 0.00% | 25.07M |
| ECOR1 CAPITAL, LLC | 2.82M | 0 | 0.00% | 21.51M |
| ALPHABET INC. | 2.82M | 0 | 0.00% | 21.51M |
| WELLINGTON MANAGEMENT GROUP LLP | 2.79M | -29.05K | -1.03% | 21.25M |
| ENAVATE SCIENCES GP, LLC | 2.63M | 0 | 0.00% | 20.02M |
| CITADEL ADVISORS LLC | 2.62M | 89.06K | +3.52% | 19.95M |
| NOVO HOLDINGS A/S | 2.25M | 64.08K | +2.93% | 17.14M |
| BLACKROCK, INC. | 2.15M | 65.74K | +3.15% | 16.41M |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.01M | 1.47M | +272.49% | 15.28M |
| LAURION CAPITAL MANAGEMENT LP | 2.00M | 80.05K | +4.16% | 15.26M |
| ARMISTICE CAPITAL, LLC | 1.76M | 436.00K | +32.83% | 13.44M |
| STATE STREET CORP | 1.04M | 810.29K | +358.10% | 7.90M |
| AISLING CAPITAL MANAGEMENT LP | 1.02M | 0 | 0.00% | 7.76M |
| OPALEYE MANAGEMENT INC. | 700.00K | 646.72K | +1213.76% | 5.33M |
| GEODE CAPITAL MANAGEMENT, LLC | 622.35K | 43.12K | +7.44% | 4.74M |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 558.53K | 327.49K | +141.74% | 4.26M |
| SPHERA FUNDS MANAGEMENT LTD. | 460.99K | 460.99K | New | 3.51M |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 400.00K | 0 | 0.00% | 3.05M |
| ROYCE & ASSOCIATES LP | 384.94K | -251.58K | -39.52% | 2.93M |
| CATALIO CAPITAL MANAGEMENT, LP | 318.41K | 318.41K | New | 2.43M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 300.00K | -137.89K | -31.49% | 2.29M |
| VANGUARD FIDUCIARY TRUST CO | 291.52K | 37.19K | +14.62% | 2.22M |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 286.52K | 286.52K | New | 2.18M |
Earnings and financials
BridgeBio Oncology Therapeutics Inc. (BBOT) trades at $2.69, with a market cap of $215.27M and a trailing P/E of n/a. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Insights · Dividends · Forecast · Financials · Learn